Amer Rana

Amer Rana is an Associate Professor in Biomedicine at the School of Biological Sciences, University of East Anglia (UEA), where he is based at the Bio-Medical Research Centre (BMRC). He holds active research projects funded by the British Heart Foundation, Medical Research Council, AstraZeneca, and the Royal Embassy of Saudi Arabia Cultural Bureau.

Research Interests: His research spans biomedicine with a focus on vascular biology, pulmonary arterial hypertension (PAH), induced pluripotent stem cells (iPSCs), endothelial cell heterogeneity, regenerative medicine, and viral latency in myeloid cells. He investigates molecular mechanisms underlying PAH, develops toxicological screening systems, and models neurovascular transmission using advanced cellular models.

Publication Trends: Recent publications highlight his work on BMPR2 signaling in PAH, iPSC-based disease modeling, endothelial progenitor cell applications, and viral latency in myeloid cells. These reflect a strong integration of stem cell technology, molecular pathology, and translational biomedicine.

Scientific Awards:

• No scientific awards mentioned in the provided text.

Advising and Grants:

• Currently leads and co-leads multiple research projects with significant external funding.
• Projects include: “Neurovascular transmission in carotid arteries” (British Heart Foundation), “Modeling endothelial cell heterogeneity with iPSCs” (Royal Embassy of Saudi Arabia), “Purinergic control of neurogenic venous tone” (British Heart Foundation), and “Generating a toxicological screening system for drug-induced pulmonary hypertension” (MRC and AstraZeneca).
• No formal advisees or students are listed in the provided information.

Labs and Teams: Dr. Rana is affiliated with the Bio-Medical Research Centre (BMRC) at UEA and collaborates extensively within multidisciplinary teams focusing on cardiovascular and respiratory diseases, stem cell modeling, and virology. His work involves collaboration with experts in virology, vascular biology, and regenerative medicine.